Multiple systematic reviews and meta-analyses of randomized controlled trials now report that, in women with PCOS, GLP-1 receptor agonists produce significant reductions in body weight, BMI, and waist circumference, together with improvements in insulin resistance measured as fasting insulin and HOMA-IR, modest reductions in total testosterone, and increases in SHBG
Our skilled team understands that responses to weight loss medications vary based on factors like starting weight, dose adherence, and lifestyle changes
Like semaglutide, it has regulatory approval for certain uses
Important Safety Information
This increased sensitivity to ferroptosis inducers is further supported by the high sensitivity of LAMP-2 mutated cells to ferroptosis (53)